O que podemos dizer sobre o Pronatec

Analisa aspectos da educação profissional brasileira, que, a partir de 2011, passou a contar com uma nova iniciativa governamental, o Programa Nacional de Acesso ao Ensino Técnico e Emprego (Pronatec), instituído por meio da Lei nº 12.513, de 26 de outubro de 2011.

Execução Orçamentária da União em Ações e Serviços Públicos de Saúde entre 2012 e 2015 e Apuração dos Recursos Mínimos a Serem Aplicados no Referido Período

Breve histórico do Sistema Nacional de Saúde e do respectivo financiamento a partir da Emenda Constitucional da Saúde até 2015, apresenta dados afetos à execução orçamentária da União em Ações e Serviços Públicos de Saúde (ASPS) a partir da vigência da Lei Complementar nº 141, de 2012, e estima o mínimo constitucional a ser aplicado frente à legislação e às revisões do PIB pelo IBGE.

Previsão de recursos na Lei Orçamentária de 2016 para projetos de lei de criação de cargos e funções na Justiça do Trabalho

Analisa aspectos da criação de cargos em diversos órgãos no âmbito da Justiça do Trabalho, que foram examinados pela Comissão de Trabalho, Administração e Serviço Público e que encontram-se na Comissão de Finanças e Tributação, aguardando o pronunciamento do colegiado.

Health-Related Quality of Life, Costs and Treatment of Inflammatory Rheumatic Diseases in Routine Practice : With special emphasis on biological drugs

Rheumatoid arthritis (RA) and other chronic inflammatory joint diseases already begin to affect patients health-related quality of life (HRQoL) in the earliest phases of these diseases. In treatment of inflammatory joint diseases, the last two decades have seen new strategies and treatment options introduced. Treatment is started at an earlier phase; combinations of disease-modifying anti-rheumatic drugs (DMARDs) and corticosteroids are used; and in refractory cases new drugs such as tumour necrosis factor (TNF) inhibitors or other biologicals can be started. In patients with new referrals to the Department of Rheumatology of the Helsinki University Central Hospital, we evaluated the 15D and the Stanford Health Assessment Questionnaire (HAQ) results at baseline and approximately 8 months after their first visit. Altogether the analysis included 295 patients with various rheumatic diseases. The mean baseline 15D score (0.822, SD 0.114) was significantly lower than for the age-matched general population (0.903, SD 0.098). Patients with osteoarthritis (OA) and spondyloarthropathies (SPA) reported the poorest HRQoL. In patients with RA and reactive arthritis (ReA) the HRQoL improved in a statistically significant manner during the 8-month follow-up. In addition, a clinically important change appeared in patients with systemic rheumatic diseases. HAQ score improved significantly in patients with RA, arthralgia and fibromyalgia, and ReA. In a study of 97 RA patients treated either with etanercept or adalimumab, we assessed their HRQoL with the RAND 36-Item Health Survey 1.0 (RAND-36) questionnaire. We also analysed changes in clinical parameters and the HAQ. With etanercept and adalimumab, the values of all domains in the RAND-36 questionnaire increased during the first 3 months. The efficacy of each in improving HRQoL was statistically significant, and the drug effects were comparable. Compared to Finnish age- and sex-matched general population values, the HRQoL of the RA patients was significantly lower at baseline and, despite the improvement, remained lower also at follow-up. Our RA patients had long-standing and severe disease that can explain the low HRQoL also at follow-up. In a pharmacoeconomic study of patients treated with infliximab we evaluated medical and work disability costs for patients with chronic inflammatory joint disease during one year before and one year after institution of infliximab treatment. Clinical and economic data for 96 patients with different arthritis diagnoses showed, in all patients, significantly improved clinical and laboratory variables. However, the medical costs increased significantly during the second period by 12 015 (95% confidence interval, 6 496 to 18 076). Only a minimal decrease in work disability costs occurred mean decrease 130 (-1 268 to 1 072). In a study involving a switch from infliximab to etanercept, we investigated the clinical outcome in 49 patients with RA. Reasons for switching were in 42% failure to respond by American College of Rheumatology (ACR) 50% criteria; in 12% adverse event; and in 46% non-medical reasons although the patients had responded to infliximab. The Disease Activity Score with 28 joints examined (DAS28) allowed us to measure patients disease activity and compare outcome between groups based on the reason for switching. In the patients in whom infliximab was switched to etanercept for nonmedical reasons, etanercept continued to suppress disease activity effectively, and 1-year drug survival for etanercept was 77% (95% CI, 62 to 97). In patients in the infliximab failure and adverse event groups, DAS28 values improved significantly during etanercept therapy. However, the 1-year drug survival of etanercept was only 43% (95% CI, 26 to 70) and 50% (95% CI, 33 to 100), respectively. Although the HRQoL of patients with inflammatory joint diseases is significantly lower than that of the general population, use of early and aggressive treatment strategies including TNF-inhibitors can improve patients HRQoL effectively. Further research is needed in finding new treatment strategies for those patients who fail to respond or lose their response to TNF-inhibitors.

Disposições sobre a legislação tributária pelas Leis de Diretrizes Orçamentárias, nos termos do art. 165, § 2º, da Constituição

Consultoria de Orçamento e Fiscalização Financeira.

Proposições legislativas e uso da margem de expansão das despesas obrigatórias continuadas nas leis de diretrizes orçamentárias

Inclui anexo : Estudo técnico n. 4/2008.

Ampliação de benefícios tributários à luz da LRF, limites do poder regulamentar e afronta às prerrogativas do Poder Legislativo : atos decorrentes do Parecer PGFN/CAT/Nº 1503/2010 - inclusão de dependente homoafetiva para efeitos fiscais

Consultoria de Orçamento e Fiscalização Financeira - Núcleo Execução e Avaliação da Despesa Pública.

Inconsistências orçamentárias e financeiras na MP n. 481/2010

Nome do autor na página de rosto: Salvador Roque Batita Júnior.

Impacto do reajuste no Programa Bolsa Família sobre o orçamento da União

Contém tabelas sobre o Histórico dos Reajustes de Valores do Bolsa Família. Consultoria de Orçamento e Fiscalização Financeira - Núcleo Trabalho, Previdência e Assistência Social.

Licitações - Regime Diferenciado de Contratações Públicas - RDC : Medida Provisória 521, de 2010

Consultoria de Orçamento e Fiscalização Financeira.

Como tornar uma proposição legislativa compatível e adequada sob o prisma orçamentário e financeiro : versão 2012

Consultoria de Orçamento e Fiscalização Financeira.